In the News

The Pharmaceutical Printed Literature Association (PPLA) hails Congresswoman Perez for supporting the bipartisan Patients’ Right to Know Their Medication Act, which aims to standardize medication information, reduce confusion, and improve patient adherence. The act is co-sponsored by several representatives and supported by the PPLA to ensure clear, accessible medication information for all Americans. Read More

The Pharmaceutical Printed Literature Association (PPLA) praises Congresswoman Peltola for supporting the Patients’ Right to Know Their Medication Act, aiming to standardize medication information and reduce medication-related issues. The lack of standardization causes confusion and non-adherence, leading to adverse events and high costs. The bipartisan bill aims to improve patient safety and minimize risks. Read More

The Centers for Medicare and Medicaid Services’ (CMS) decision to cease providing printed data to researchers is harmful! Virtual databases create barriers, delays, and disproportionally affect institutions with fewer technological resources. We urge CMS to reconsider its decision and prioritize research quality and accessibility. CMS’ efficacy depends on it. Read More

The Pharmaceutical Printed Literature Association (PPLA) emphasized the vital role of printed Patient Medication Information (PMI) for patient safety in rural areas. They oppose proposals to shift PMI to digital-only formats, arguing that rural residents face unique challenges, like limited broadband access, which makes printed PMI crucial for safe medication management. They support the Patients’… Read More

Press Release : PPLA Washington, D.C. (January 29th, 2024) – A new report from Punchbowl News highlighted the worsening outlook for the Federal Communications Commission’s (FCC) Affordable Connectivity Program, underscoring Read More

The Pharmaceutical Printed Literature Association (PPLA) and bipartisan lawmakers are urging the FDA to revise its proposed rule on patient medication information. They argue that the current digital format may hinder patient access, particularly for the elderly and rural communities. They emphasize the importance of easily accessible, printed medication information for better health outcomes. Read More

The Pharmaceutical Printed Literature Association (PPLA) highlighted bipartisan Congressional support for the Patients’ Right to Know Their Medication Act (H.R. 1173). This legislation aims to protect patients’ access to printed Patient Medication Information (PMI), which is crucial for medication adherence. The bill requires standardized printed PMI approved by the FDA and opposes a proposed rule… Read More

Congressman Jared Golden reintroduced the Patients’ Right to Know Their Medication Act, requiring drug manufacturers to include printed inserts with medication information to ensure rural Americans and seniors have access to vital details. This aims to support rural residents, seniors, and the local job market. Read More

Two Sides North America welcomes the Pharmaceutical Printed Literature Association (PPLA) as a new member. PPLA advocates for printed medical information, supporting patient safety and environmental responsibility in medication communication. Read More

The Association of Mature American Citizens (AMAC) supports the Patients’ Right to Know Their Medication Act, advocating for clear and standardized prescription medication information to empower seniors and improve health outcomes, urging Congressmen Golden and Carter to take action. Read More